Add a New Bulls Reason

Company: Biogen Idec (BIIB)
Current price:
Headline: (100 character max)
Analysis:
Cancel
100%
agree
3 votes

edit Potential upside from Tysabri

Upcoming safety reports on wild-card drug Tysabri could dismiss previous safety concerns, generating significant upside for the company.

(100 character max) Cancel
0%
agree
0 votes

edit Avonex and Rituxan are groundbreaking drugs

Both Avonex and Rituxan are groundbreaking drugs that lead their respective markets, giving Biogen Idec a solid foundation for stable growth.

(100 character max) Cancel
0%
agree
0 votes

edit Large research and development budget

Biogen Idec has the third-largest research and development budget amongst biotech firms, giving it the means to repeat its successes with Avonex and Rituxan.

(100 character max) Cancel
Wikinvest © 2006, 2007, 2008, 2009. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki